RECRUITING

Families, Responsibility, Education, Support, and Health for Executive Function

Talk to us

Conditions

Overweight and ObesityAttention-Deficit Hyperactivity Disorderweight lossexecutive functionparent-based treatment

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The pilot study will be a one group open-label treatment program and will be used to refine a parent-based behavioral treatment enhanced with executive-function training (PBT-EF) for children with comorbid overweight or obesity and Attention-Deficit Hyperactivity Disorder (ADHD).

Official Title

Executive Function Enhanced Parent-Based Treatment for Children With ADHD and Overweight or Obesity

Quick Facts

Study Start:2022-07-26
Study Completion:2024-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05165511

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:8 Years to 12 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. * Child with overweight or obesity (85-99.9% BMI for age),
  2. * Child age 8-12,
  3. * Child with a diagnosis of ADHD,
  4. * A parent willing to participate who can read and understand English at a minimum of a fifth-grade level, able to attend treatment sessions remotely via Zoom on video.
  1. * Current enrollment in an organized weight control program (parent and child)
  2. * Medication specifically prescribed for weight loss (child)
  3. * Medical or psychiatric condition that may interfere with treatment participation or that may require physician monitoring of diet and/or exercise (e.g., acute suicidality; psychosis; substance use disorder) (parent and child)
  4. * Change in psychotropic medication or other medication that may impact weight or ADHD symptoms during the previous 3 months (child)

Contacts and Locations

Study Contact

Allison S Tietz, BS
CONTACT
(858)380-5579
astietz@health.ucsd.edu
Dawn M Eichen, PhD
CONTACT
(858)534-8322
deichen@ucsd.edu

Principal Investigator

Dawn M Eichen, PhD
PRINCIPAL_INVESTIGATOR
University of California, San Diego

Study Locations (Sites)

UCSD Center for Healthy Eating and Activity Research (CHEAR)
San Diego, California, 92037
United States

Collaborators and Investigators

Sponsor: University of California, San Diego

  • Dawn M Eichen, PhD, PRINCIPAL_INVESTIGATOR, University of California, San Diego

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-07-26
Study Completion Date2024-12

Study Record Updates

Study Start Date2022-07-26
Study Completion Date2024-12

Terms related to this study

Keywords Provided by Researchers

  • weight loss
  • executive function
  • parent-based treatment

Additional Relevant MeSH Terms

  • Overweight and Obesity
  • Attention-Deficit Hyperactivity Disorder